advertisement
11.4 Prostaglandins (20)
Showing records 1 to 20
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins28153 A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost
Craven ER; Liu C-C; Batoosingh A; Schiffman RM; Whitcup SM
Clinical Ophthalmology 2010; 4: 1433-1440
28151 Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
Katz G; Springs CL; Craven ER; Montecchi-Palmer M
Clinical Ophthalmology 2010; 4: 1253-1261
27906 The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo
Sehi M; Grewal DS; Feuer WJ; Greenfield DS
Vision Research 2011; 51: 235-242
28113 Long-term effect of latanoprost on central corneal thickness in normal tension glaucoma
Kim HJ; Cho BJ
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 73-76
28081 A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in chinese patients with primary angle-closure and primary angle-closure glaucoma
Wu LL; Huang P; Gao YX; Wang ZX; Li B
Journal of Glaucoma 2011; Epub ahead of print
27826 Bilateral and simultaneous cystoid macular edema associated with latanoprost use: report of two cases
Brasil OFM; Brasil MVM; Ventura MP; Maia HS
Arquivos Brasileiros de Oftalmologia 2010; 73: 186-188
27681 Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost
Park J; Cho HK; Moon JI
Japanese Journal of Ophthalmology 2011; 55: 22-27
27827 Prostaglandin F(2)(alpha) stimulates human hair follicles via receptors located within the follicle itself
Khidhir KG; Farjo NP; Woodward DF; Picksley SM; Randall VA
British Journal of Dermatology 2010; 162: 916
27940 Periorbital fat atrophy - An unfamiliar side effect of prostaglandin analogues
Jayaprakasam A; Ghazi-Nouri S
Orbit 2010; 29: 357-359
28111 Bimatoprost versus travoprost in an egyptian population: A Hospital-based prospective, randomized study
MacKy TA
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 605-610
28046 Research progress of prostaglandin receptors and related drugs
Xu H; Sun H-B
Journal of China Pharmaceutical University 2010; 41: 385-394
28155 Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
Miyashiro MJ; Lo SC; Stewart JA; Stewart WC
Clinical Ophthalmology 2010; 4: 1355-1359
28003 Topical antiglaucoma treatment with prostaglandin analogues may precipitate meibomian Gland disease
Cunniffe MG; Medel-Jimenez R; Gonzalez-Candial M
Ophthalmic Plastic and Reconstructive Surgery 2010; Epub ahead of print
28145 Paired-eye comparison of medical therapies for glaucoma
Solish AM; James F; Walt JG; Chiang TH
Clinical Ophthalmology 2010; 4: 1131-1135
28147 Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: Patient considerations
Suzuki Jr ER; Suzuki CLB
Clinical Ophthalmology 2010; 4: 1165-1171
28149 Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
Pozarowska D
Clinical Ophthalmology 2010; 4: 1229-1236
28150 Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
Schnober D; Hofmann G; Maier H; Scherzer M-L; Ogundele AB; Jasek MC
Clinical Ophthalmology 2010; 4: 1459-1463
27986 Interaction of the antiglaucoma prostanoid latanoprost with the prostaglandin transporter OATP2A1
Kraft ME; Zolk O; Welge-Lussen U; Schlotzer-Schrehardt U; Kruse FE; Glaeser H; Mandery K; Konig J; Fromm MF
British Journal of Clinical Pharmacology 2009; 68: 3
28234 Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride
Stankiewicz A; Misiuk-Hoja o M; Grabska-Liberek I; Romanowska-Dixon B; Wierzbowska J; Wasyluk J; Mulak M; Szuacik I; Sierdziaski J; Ehrlich R
Acta Ophthalmologica 2011; 89: 57-63
28140 Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
Schmier JK; Lau EC; Covert DW
Clinical Ophthalmology 2010; 4: 1137-1143
